Corporate Fellows

For his seminal work on elucidating key molecular-scale mechanisms that govern biogeochemical transformation of contaminants, trace metals, and natural organic matter, which has made significant contributions to the understanding of natural organic and metal cycling in terrestrial ecosystems and remediation of contaminated sites, and also for his contributions to the development of the next generation of scientists and engineers.

For pioneering advances in the field of materials chemistry for the design, synthesis and fabrication of new materials and their translation into new energy technologies, including superconductor wires, electrodes for batteries, solar cells, lithium extraction from geothermal brine and additive manufacturing of magnets, and also for his leadership in developing the next generation of scientists and engineers.

Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.

Jerry is recognized for distinguished research on the genetic basis of tree growth and development, including leading the international efforts to sequence, assemble, and annotate the genomes of poplar and eucalyptus bioenergy feedstocks.

For research in the fields of astrophysics and supernova science.

For studies of the electronic structure of molecules, computational chemistry, and high-performance algorithms and computing.

For developments in biomedical engineering and biotechnology, micromechanical devices, and nanoscale imaging and detection.

For his internationally recognized accomplishments in high-energy physics, radiation transport, and detector and neutron target research and development.

For significant contributions and leadership in the processing and properties of materials, particularly intermetallic alloys, which have led to his reputation as one of the world's leading scientists in these areas.

For international leadership in developing innovative therapeutic and diagnostic applications of radionuclides for nuclear medicine.